Mifamurtide sodium hydrate
Modify Date: 2024-01-28 18:03:25
Mifamurtide sodium hydrate structure
|
Common Name | Mifamurtide sodium hydrate | ||
|---|---|---|---|---|
| CAS Number | 838853-48-8 | Molecular Weight | 1277.496 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C59H110N6NaO20P | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Mifamurtide sodium hydrateMifamurtide (sodium hydrate) (MTP-PE (sodium hydrate); L-MTP-PE (sodium hydrate); CGP 19835 (sodium hydrate)) is the sodium hydrate of mifamurtide. Mifamurtide is a nonspecific immunomodulator that acts by stimulating immune responses by activating macrophages and monocytes. Mifamurtide is a specific ligand for NOD2 and is used as an insulin sensitizer and may also be used in osteosarcoma research[1][2][3]. |
| Name | Mifamurtide hydrate |
|---|---|
| Synonym | More Synonyms |
| Description | Mifamurtide (sodium hydrate) (MTP-PE (sodium hydrate); L-MTP-PE (sodium hydrate); CGP 19835 (sodium hydrate)) is the sodium hydrate of mifamurtide. Mifamurtide is a nonspecific immunomodulator that acts by stimulating immune responses by activating macrophages and monocytes. Mifamurtide is a specific ligand for NOD2 and is used as an insulin sensitizer and may also be used in osteosarcoma research[1][2][3]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C59H110N6NaO20P |
|---|---|
| Molecular Weight | 1277.496 |
| Exact Mass | 1276.740967 |
| Mifamurtide |
| Sodium (5S,10R,13S,16R)-16-{[(3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl]oxy}-10-carbamoyl-5,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadec-1-yl (2R)-2,3-bis(palmitoyloxy)propyl phosphate hydrate (1:1:1) |